Glucocerebroside treatment of disease
CA 2540666 C · Owner: Ilan, Yaron · Inventors: Ilan, Yaron; Zimran, Ari; Margalit, Maya
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides a method for the treatment of immune mediated or immune related diseases or disorders infectious diseases, metabolic , disorders and cancer in mammalian subjects. This method comprises the administration of a naturally occurring mammalian intermediary metabolite or , T cell receptor ligand preferably a glucosylceramide, to a mammalian subject. In a preferred embodiment, such mammalian subjects are human beings.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 20, 2004 and granted January 13, 2015. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended September 20, 2024.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 20, 2026.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.